TEXAS CAPITAL BANCSHARES INC/TX
Data quality: 83%
TCBIO
NASDAQ
Financial Services
Depository Institutions
$21.70
▼
$0.08
(-0.37%)
Mkt Cap: 1.00 B
Price
$21.78
Mkt Cap
1.00 B
Day Range
—
52-Week Range
—
Volume
—
Open —
50D / 200D Avg
—
50D / 200D Avg
—
Quick Summary
Key Takeaways
Earnings grew 326.08% over the past year
Debt/Equity of 0.17 — conservative balance sheet
Generating 347.59 M in free cash flow
P/E of 3.04 — trading at a low valuation
PEG of 0.45 suggests growth is underpriced
Cash machine — converts 105.25% of earnings into free cash flow
Growth
Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)326.08%
FCF Growth (3Y)-1.38%
Quality
Return on Equity
9.24%
Above sector avg (9.22%)
ROICN/A
Net MarginN/A
Op. MarginN/A
Safety
Debt / Equity
0.17
Below sector avg (0.49)
Current RatioN/A
Interest CoverageN/A
Valuation
PE (TTM)
3.04
Below sector avg (11.12)
P/B Ratio0.28
EV/EBITDAN/A
Dividend Yield6.59%
Price History
Financial Trends
Peer Comparison
vs Financial Services sector median (2698 peers)
Peer Comparison
vs Financial Services sector median (2698 peers)| Metric | Stock | Sector Median |
|---|---|---|
| P/E | 3.0 | 11.1 |
| P/B | 0.3 | 1.2 |
| ROE % | 9.2 | 9.2 |
| Net Margin % | — | 9.4 |
| Rev Growth 5Y % | — | 5.8 |
| D/E | 0.2 | 0.5 |
Analyst Price Target
No analyst coverage available
Earnings Estimates
| Period | EPS Est. | Revenue Est. | Analysts |
|---|---|---|---|
| FY2027 | — | 1.45 B | — |
| FY2026 | — | 1.35 B | — |
| Period | EPS Est. | Revenue Est. | Analysts |
|---|---|---|---|
| 2026 Q2 | — | 333.56 M | — |
| 2026 Q1 | — | 318.64 M | — |
Dividend History
Yield
6.59%
Payout Ratio
21.15%
Growth (3Y)
0.00%
Growth (5Y)
N/A
| Ex-Date | Payment Date | Amount | Yield |
|---|---|---|---|
| Mar 02, 2026 | — | $0.36 | N/A |
| Dec 01, 2025 | — | $0.36 | N/A |
| Sep 02, 2025 | — | $0.36 | N/A |
| Jun 02, 2025 | — | $0.36 | N/A |
| Mar 03, 2025 | — | $0.36 | N/A |
| Dec 02, 2024 | — | $0.36 | N/A |
| Sep 03, 2024 | — | $0.36 | N/A |
| Jun 03, 2024 | — | $0.36 | N/A |
| Feb 29, 2024 | — | $0.36 | N/A |
| Nov 30, 2023 | — | $0.36 | N/A |
| Aug 31, 2023 | — | $0.36 | N/A |
| May 31, 2023 | — | $0.36 | N/A |
| Feb 28, 2023 | — | $0.36 | N/A |
| Nov 30, 2022 | — | $0.36 | N/A |
| Aug 31, 2022 | — | $0.36 | N/A |
| May 31, 2022 | — | $0.36 | N/A |
| Feb 28, 2022 | — | $0.36 | N/A |
| Nov 30, 2021 | — | $0.36 | N/A |
| Aug 31, 2021 | — | $0.36 | N/A |
| May 28, 2021 | — | $0.36 | N/A |
All Fundamental Metrics
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | N/A | Revenue Growth (3Y) | N/A |
| Earnings Growth (1Y) | 326.08% | Earnings Growth (3Y) | 32.14% |
| Revenue Growth (5Y) | N/A | Earnings Growth (5Y) | 6.79% |
| Profitability | |||
| Revenue (TTM) | N/A | Net Income (TTM) | 330.24 M |
| ROE | 9.24% | ROA | 1.02% |
| Gross Margin | N/A | Operating Margin | N/A |
| Net Margin | N/A | Free Cash Flow (TTM) | 347.59 M |
| ROIC | N/A | FCF Growth (3Y) | -1.38% |
| Safety | |||
| Debt / Equity | 0.17 | Current Ratio | N/A |
| Interest Coverage | N/A | Asset Turnover | N/A |
| Working Capital | N/A | Tangible Book Value | 3.64 B |
| Dividends | |||
| Dividend Yield | 6.59% | Payout Ratio | 21.15% |
| Dividend Growth (3Y) | 0.00% | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | 5 yrs | ||
| Valuation | |||
| P/E Ratio | 3.04 | Forward P/E | N/A |
| P/B Ratio | 0.28 | P/S Ratio | N/A |
| PEG Ratio | 0.45 | Forward PEG | N/A |
| EV/EBITDA | N/A | Fwd EV/EBITDA | N/A |
| Forward P/S | 0.69 | Fwd Earnings Yield | N/A |
| FCF Yield | 34.60% | ||
| Market Cap | 1.00 B | Enterprise Value | 1.63 B |
| Per Share | |||
| EPS (Diluted TTM) | 6.79 | Revenue / Share | N/A |
| FCF / Share | 7.54 | OCF / Share | 7.81 |
| EPS CAGR (1Y) | 430.47% | EPS CAGR (5Y) | 10.22% |
| EPS CAGR (10Y) | 9.06% | ||
| Efficiency | |||
| CapEx / Revenue | N/A | FCF Conversion | 105.25% |
| SBC-Adj. FCF | 312.52 M | Growth Momentum | N/A |
Income Statement
Annual, most recent first
Income Statement
Annual, most recent first| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | — | — | — | — | — |
| Net Income | 330.24 M | 77.51 M | 189.14 M | 332.48 M | 253.94 M |
| EPS (Diluted) | 6.79 | 1.28 | 3.54 | 6.18 | 4.60 |
| Gross Profit | — | — | — | — | — |
| Operating Income | — | — | — | — | — |
| EBITDA | — | — | — | — | — |
| R&D Expenses | — | — | — | — | — |
| SG&A Expenses | — | — | — | — | — |
| D&A | 52.17 M | 54.23 M | 40.47 M | 45.28 M | 93.41 M |
| Interest Expense | 1.03 B | 901.30 M | 715.80 M | 268.48 M | 107.75 M |
| Income Tax | 102.47 M | 29.55 M | 57.45 M | 99.28 M | 84.12 M |
Balance Sheet
Annual, most recent first
Balance Sheet
Annual, most recent first| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 31.54 B | 30.73 B | 28.36 B | 28.41 B | 34.73 B |
| Total Liabilities | 27.91 B | 27.36 B | 25.16 B | 25.36 B | 31.52 B |
| Shareholders' Equity | 3.63 B | 3.37 B | 3.20 B | 3.06 B | 3.21 B |
| Total Debt | 620.58 M | 660.35 M | 859.15 M | 931.44 M | 928.74 M |
| Cash & Equivalents | — | — | — | — | — |
| Current Assets | — | — | — | — | — |
| Current Liabilities | — | — | — | — | — |
Strategy Scores
This stock passed the criteria for 3 strategies
Score = fit strength (0–100)
Rank = position among all matches
Recent Activity
Entered
High Yield Value
Apr 12, 2026
Entered
Deep Value Investing (Seth Klarman)
Apr 12, 2026
Entered
Defensive Investing (Benjamin Graham)
Apr 12, 2026
{"event":"ticker_viewed","properties":{"ticker":"TCBIO","listing_kind":"stock","pathname":"/stocks/tcbio","exchange":"NASDAQ","country":"US"}}